Header image for Robotic Summit 2025
Profile image for Spinal Cord Injury Treatment of the Future

Spinal Cord Injury Treatment of the Future

Thursday November 20, 2025 16:30 - 16:50 CET Mainroom

Lecturer: Gil Hakim

tba

Lecturers

Profile image for Gil Hakim

Gil Hakim Lecturer

CEO

With over 20 years of experience in life sciences, specializing in early-stage innovation and market strategy. Previously with Urogen Pharma (NASDAQ: URGN), he holds a B.Sc. in Life Sciences from Ben-Gurion University.